Rapid Impact: Getting Interventions into Hospitals, To Patients, & To Communities
December 1, 2020
In the chaos of a pandemic, we identify new problems daily, emphasizing the need for innovation. Frontline healthcare workers are reinventing their protocols and workflows while simultaneously caring for the sick. Armies of researchers work frantically to find ways to lighten the load, but their innovations are only the beginning. An intervention is only beneficial if it is being used.
Join TR talks to discuss how to get your innovations into the hands of those who need it most.
Rapid Approvals - COVID Pivots, Models and Sustainability
November 3, 2020
The regulatory runways for translating research into commercialization have been the subject of many debates. Priorities and trade-offs based on costs, timelines, and safety considerations have created significant differences across jurisdictions and application domains.
During the COVID-19 pandemic we have seen countless examples of expedited approvals and implementations of innovations from proof-of-concept to product proving that rapid innovation and expedited go to market strategies are possible. What are the lessons that we can take from the current situation to improve our translational pathways to ensure effective, safe, and timely commercialization of health innovations?
Join TR talks this week to discuss the benefits and shortcomings of pathways, pivots, successes, and failures of go-to-market strategies during COVID. What should we keep in a post-COVID world?
Ethics & Patients in Research
October 6, 2020
A defining characteristic of translational research is collaboration is an important aspect of health science innovation. When trying to improve people’s health, we need to work with the peoples’ whose health we’re trying to improve. Although this seems self-evident and simple, it is not done as often as it should. How do we do better?
Join TR talks this week as we discuss the nature of effective collaboration with patients, in translational research and the barriers to making it a reality.
How Has COVID Changed Translation?
September 8, 2020
COVID-19 has disrupted the world. We are changing almost every aspect of our lives from the way we walk down the street to the way we socialize, shop, study, and work. The challenges of this pandemic also provide opportunities for science led decision-making to innovate policy, regulation, ethics, intellectual property, and funding opportunities.
Join TR Talks as we discuss how science-driven translational of research, can help us establish evidence-based sound responses, policies, and innovations for a solid foundation during and after a pandemic.